Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes. [electronic resource] by
- Sha, Sue
- Devineni, Damayanthi
- Ghosh, Atalanta
- Polidori, David
- Hompesch, Marcus
- Arnolds, Sabine
- Morrow, Linda
- Spitzer, Heike
- Demarest, Keith
- Rothenberg, Paul
Producer: 20151005
In:
PloS one vol. 9
Availability: No items available.
|
|
|
18.
|
Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes. [electronic resource] by
- Sha, Sue
- Devineni, Damayanthi
- Ghosh, Atalanta
- Polidori, David
- Hompesch, Marcus
- Arnolds, Sabine
- Morrow, Linda
- Spitzer, Heike
- Demarest, Keith
- Rothenberg, Paul
Producer: 20151221
In:
PloS one vol. 9
Availability: No items available.
|
|
|
19.
|
Effect of hepatic or renal impairment on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor. [electronic resource] by
- Devineni, Damayanthi
- Curtin, Christopher R
- Marbury, Thomas C
- Smith, William
- Vaccaro, Nicole
- Wexler, David
- Vandebosch, An
- Rusch, Sarah
- Stieltjes, Hans
- Wajs, Ewa
Producer: 20160329
In:
Clinical therapeutics vol. 37
Availability: No items available.
|
|
|
20.
|
Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men. [electronic resource] by
- Cirillo, Iolanda
- Mannens, Geert
- Janssen, Cor
- Vermeir, Marc
- Cuyckens, Filip
- Desai-Krieger, Daksha
- Vaccaro, Nicole
- Kao, L Mark
- Devineni, Damayanthi
- Redman, Rebecca
- Turner, Kenneth
Producer: 20090109
In:
Antimicrobial agents and chemotherapy vol. 52
Availability: No items available.
|